Clinical Trial Update: Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring sublingual tablets with cannabinoid combinations for dysmenorrhea and related symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Fatigue
• Headache
• Migraine
• Mood Disturbance
• Nausea

Drugs mentioned

• Pure Green sublingual cannabinoid tablets (investigational)

Snippet

Sponsor: Pure Green | Conditions: Dysmenorrhea, Headache, Migraine | Phase 2 | Status: UNKNOWN